Monoamine Oxidase Inhibition for Tobacco Pharmacotherapy
- 19 December 2007
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 83 (4) , 619-621
- https://doi.org/10.1038/sj.clpt.6100474
Abstract
Tobacco addiction is the most significant preventable cause of morbidity and mortality in the Western world, with >430,000 deaths annually from tobacco-related diseases being reported in the United S...Keywords
This publication has 23 references indexed in Scilit:
- Monoamine oxidase and tobacco dependencePublished by Elsevier ,2006
- Monoamine oxidase polymorphisms and smoking behaviour in JapanesePharmacogenetics, 2003
- A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessationBiological Psychiatry, 2003
- Transdermal Selegiline in Major Depression: A Double-Blind, Placebo-Controlled, Parallel-Group Study in OutpatientsAmerican Journal of Psychiatry, 2002
- Epidemiology of tobacco use in the United StatesOncogene, 2002
- Monoamine Oxidase and Cigarette SmokingNeuroToxicology, 2002
- Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessationAddiction, 2002
- Effects of selegiline (l-deprenyl) during smoking and short-term abstinencePsychopharmacology, 2002
- 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activityLife Sciences, 2001
- Isolation and Characterization of a Monoamine Oxidase Inhibitor from Tobacco LeavesChemical Research in Toxicology, 1999